AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials
VJHemOnc Podcast
Discussion on Belantham F in older patients and the significance of MOD as a surrogate endpoint in myeloma trials
Exploring the safety and efficacy of Belantham F in patients over 90 years old and the importance of MOD data in myeloma trials as a predictive endpoint for clinical benefit and approval acceleration.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode